- Home
- BFH vs IRON Comparison
BFH vs IRON Comparison
Compare BFH & IRON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BFH
- IRON
- Stock Information
- Founded
- BFH 1996
- IRON 2017
- Country
- BFH United States
- IRON United States
- Employees
- BFH N/A
- IRON N/A
- Industry
- BFH Business Services
- IRON Biotechnology: Pharmaceutical Preparations
- Sector
- BFH Consumer Discretionary
- IRON Health Care
- Exchange
- BFH Nasdaq
- IRON Nasdaq
- Market Cap
- BFH 2.8B
- IRON 2.0B
- IPO Year
- BFH N/A
- IRON N/A
- Fundamental
- Price
- BFH $66.18
- IRON $59.25
- Analyst Decision
- BFH Hold
- IRON Strong Buy
- Analyst Count
- BFH 13
- IRON 11
- Target Price
- BFH $60.17
- IRON $95.73
- AVG Volume (30 Days)
- BFH 510.1K
- IRON 307.9K
- Earning Date
- BFH 10-23-2025
- IRON 08-07-2025
- Dividend Yield
- BFH 1.27%
- IRON N/A
- EPS Growth
- BFH N/A
- IRON N/A
- EPS
- BFH 5.76
- IRON N/A
- Revenue
- BFH $2,452,000,000.00
- IRON N/A
- Revenue This Year
- BFH $59.93
- IRON N/A
- Revenue Next Year
- BFH $4.28
- IRON N/A
- P/E Ratio
- BFH $11.29
- IRON N/A
- Revenue Growth
- BFH N/A
- IRON N/A
- 52 Week Low
- BFH $38.21
- IRON $30.82
- 52 Week High
- BFH $67.33
- IRON $68.73
- Technical
- Relative Strength Index (RSI)
- BFH 67.26
- IRON 55.65
- Support Level
- BFH $62.11
- IRON $59.50
- Resistance Level
- BFH $61.11
- IRON $61.05
- Average True Range (ATR)
- BFH 1.66
- IRON 1.79
- MACD
- BFH 0.66
- IRON -0.11
- Stochastic Oscillator
- BFH 87.29
- IRON 35.39
About BFH Bread Financial Holdings Inc.
Formed by a combination of JCPenney's credit card processing unit and The Limited's credit card bank business, Bread Financial is a provider of private-label and co-branded credit cards, loyalty programs, and marketing services. The company's most financially significant unit is its credit card business that partners with retailers to jointly market Bread's credit cards to their customers. The company also retains a minority interest in spun-off LoyaltyOne, which operates the largest airline miles loyalty program in Canada and offers marketing services to grocery chains in Europe and Asia.
About IRON Disc Medicine Inc.
Disc Medicine Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for hematologic diseases. It aims to modify fundamental biological pathways associated with the formation and function of red blood cells, specifically heme biosynthesis and iron homeostasis. Its pipeline includes bitopertin for erythropoietic porphyrias (EPs) including erythropoietic protoporphyria (EPP), X-linked protoporphyria (XLP), and Diamond-Blackfan Anemia (DBA); DISC-0974 for the treatment of anemia of myelofibrosis (MF) and anemia of chronic kidney disease (CKD); and DISC-3405 for the treatment of polycythemia vera (PV) and other hematologic disorders. In addition, the Company's preclinical programs include DISC-0998.